Enviva Inc.
EVA · NYSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $74 | $3,513 | $3,690 | $2,380 |
| - Cash | $177 | $3 | $17 | $10 |
| + Debt | $1,932 | $1,708 | $1,394 | $976 |
| Enterprise Value | $1,829 | $5,217 | $5,067 | $3,346 |
| Revenue | $1,204 | $1,094 | $1,042 | $875 |
| % Growth | 10.1% | 5% | 19% | – |
| Gross Profit | -$159 | $167 | $78 | $107 |
| % Margin | -13.2% | 15.2% | 7.5% | 12.2% |
| EBITDA | -$338 | $19 | -$14 | $22 |
| % Margin | -28% | 1.7% | -1.3% | 2.5% |
| Net Income | -$686 | -$168 | -$145 | $17 |
| % Margin | -57% | -15.4% | -13.9% | 2% |
| EPS Diluted | -9.23 | -2.51 | -2.77 | 0.33 |
| % Growth | -267.7% | 9.4% | -939.4% | – |
| Operating Cash Flow | -$66 | -$89 | $38 | $119 |
| Capital Expenditures | -$301 | -$218 | -$332 | -$100 |
| Free Cash Flow | -$367 | -$307 | -$294 | $19 |